Drug Profile
Atenolol/hydrochlorothiazide/ramipril/simvastatin - Cadila Pharmaceuticals
Alternative Names: Hydrochlorothiazide/ramipril/simvastatin/atenolol - Cadila Pharmaceuticals; Polycap 4; Ramipril/simvastatin/atenolol/hydrochlorothiazide - Cadila Pharmaceuticals; Simvastatin/atenolol/hydrochlorothiazide/ramipril - Cadila PharmaceuticalsLatest Information Update: 11 Feb 2014
Price :
$50
*
At a glance
- Originator Cadila Pharmaceuticals
- Class Antihyperlipidaemics; Antihypertensives; Benzothiadiazines; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Naphthalenes; Propanolamines
- Mechanism of Action ACE inhibitors; Beta 1 adrenergic receptor antagonists; HMG-CoA reductase inhibitors; Thiazide diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cardiovascular disorders
Most Recent Events
- 31 Jan 2014 Launched for Cardiovascular disorders (prevention) in India (PO)